BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manka P, Zeller A, Syn W. Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities. Drugs 2019;79:903-27. [DOI: 10.1007/s40265-019-01126-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Min Z. Effect of long non‑coding RNA AK021443 on promoting hepatic fibrosis in vitro. Mol Med Rep 2021;23:196. [PMID: 33495828 DOI: 10.3892/mmr.2021.11835] [Reference Citation Analysis]
2 Brovold M, Keller D, Soker S. Differential fibrotic phenotypes of hepatic stellate cells within 3D liver organoids. Biotechnol Bioeng 2020;117:2516-26. [PMID: 32391915 DOI: 10.1002/bit.27379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wang C, Ma C, Gong L, Dai S, Li Y. Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms. Eur J Pharmacol 2021;912:174604. [PMID: 34743980 DOI: 10.1016/j.ejphar.2021.174604] [Reference Citation Analysis]
4 Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: Pathophysiology and clinical implications. Wiley Interdiscip Rev Syst Biol Med. 2020;e1499. [PMID: 32713091 DOI: 10.1002/wsbm.1499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang S, Tang C, Zhao H, Shen P, Lin C, Zhu Y, Han D. Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis. Front Pharmacol 2021;12:656115. [PMID: 34276360 DOI: 10.3389/fphar.2021.656115] [Reference Citation Analysis]
6 Dunham C, Havlioglu N, Chamberlain A, Lake S, Meyer G. Adipose stem cells exhibit mechanical memory and reduce fibrotic contracture in a rat elbow injury model. FASEB J 2020;34:12976-90. [PMID: 33411380 DOI: 10.1096/fj.202001274R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Shi MJ, Xiao HM, Xie YB, Jiang JM, Zhao PT, Cai GS, Li YX, Li S, Zhang CZ, Cao ML, Chen QB, Tan ZJ, Gao HJ, Chi XL. Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes. Evid Based Complement Alternat Med 2020;2020:5956940. [PMID: 33178319 DOI: 10.1155/2020/5956940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Liu Y, Song JW, Lin JY, Miao R, Zhong JC. Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases. Cardiovasc Toxicol 2020;20:463-73. [PMID: 32856216 DOI: 10.1007/s12012-020-09603-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Bu FT, Zhu Y, Chen X, Wang A, Zhang YF, You HM, Yang Y, Yang YR, Huang C, Li J. Circular RNA circPSD3 alleviates hepatic fibrogenesis by regulating the miR-92b-3p/Smad7 axis. Mol Ther Nucleic Acids 2021;23:847-62. [PMID: 33614234 DOI: 10.1016/j.omtn.2021.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Cui E, Long W, Wu J, Li Q, Ma C, Lei Y, Lin F. Predicting the stages of liver fibrosis with multiphase CT radiomics based on volumetric features. Abdom Radiol (NY) 2021;46:3866-76. [PMID: 33751193 DOI: 10.1007/s00261-021-03051-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Yao J, Lin C, Jiang J, Zhang X, Li F, Liu T, Diao H. lncRNA-HEIM Facilitated Liver Fibrosis by Up-Regulating TGF-β Expression in Long-Term Outcome of Chronic Hepatitis B. Front Immunol 2021;12:666370. [PMID: 34168644 DOI: 10.3389/fimmu.2021.666370] [Reference Citation Analysis]
12 Czajka P, Przybyłkowski A, Nowak A, Postula M, Wolska M, Mirowska-Guzel D, Czlonkowska A, Eyileten C. Antiplatelet drugs and liver fibrosis. Platelets 2021;:1-10. [PMID: 33577391 DOI: 10.1080/09537104.2021.1883574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wang S, Shuai C, Gao S, Jiang J, Luan J, Lv X. Chemokine CXCL14 acts as a potential genetic target for liver fibrosis. Int Immunopharmacol 2020;89:107067. [PMID: 33039963 DOI: 10.1016/j.intimp.2020.107067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Xu XL, Jiang LS, Wu CS, Pan LY, Lou ZQ, Peng CT, Dong Y, Ruan B. The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? J Formos Med Assoc 2021:S0929-6646(21)00344-2. [PMID: 34325952 DOI: 10.1016/j.jfma.2021.07.013] [Reference Citation Analysis]
15 Bestion E, Jilkova ZM, Mège JL, Novello M, Kurma K, Pour STA, Lalmanach G, Vanderlynden L, Fizanne L, Bassissi F, Rachid M, Tracz J, Boursier J, Courcambeck J, Serdjebi C, Ansaldi C, Decaens T, Halfon P, Brun S. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. Ther Adv Chronic Dis 2020;11:2040622320942042. [PMID: 32728410 DOI: 10.1177/2040622320942042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Wan M, Han J, Ding L, Hu F, Gao P. Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis. Front Med (Lausanne) 2021;8:604894. [PMID: 33869241 DOI: 10.3389/fmed.2021.604894] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Xu T, Pan L, Li L, Hu S, Zhou H, Yang C, Yang J, Li H, Liu Y, Meng X, Li J. MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88. J Cell Mol Med 2020;24:7127-40. [PMID: 32463570 DOI: 10.1111/jcmm.15119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Yang G, Li S, Jin J, Xuan Y, Ding L, Huang M, Liu J, Wang B, Lan T. Protective effects of Longhu Rendan on chronic liver injury and fibrosis in mice. Liver Research 2021. [DOI: 10.1016/j.livres.2021.05.002] [Reference Citation Analysis]